Susquehanna International Group
BCYC

Susquehanna International Group’s Bicycle Therapeutics BCYC Stock Holding History

Susquehanna International Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
242,600
+148,600
+158% +$849K ﹤0.01% 7571
2025
Q4 		$666K Buy
+94,000
New +$693K ﹤0.01% 8147
2025
Q3 		– Sell
-12,800
Closed -$89K – 12386
2025
Q2 		$89K Buy
+12,800
New +$102K ﹤0.01% 11856
2025
Q1 		– Sell
-10,800
Closed -$151K – 12479
2024
Q4 		$151K Sell
10,800
-7,700
-42% -$165K ﹤0.01% 11016
2024
Q3 		$419K Buy
18,500
+8,600
+87% +$198K ﹤0.01% 8892
2024
Q2 		$200K Buy
+9,900
New +$224K ﹤0.01% 10359
2024
Q1 		– Sell
-25,500
Closed -$461K – 12169
2023
Q4 		$461K Sell
25,500
-17,500
-41% -$290K ﹤0.01% 8870
2023
Q3 		$864K Buy
43,000
+12,300
+40% +$281K ﹤0.01% 6955
2023
Q2 		$783K Sell
30,700
-6,300
-17% -$146K ﹤0.01% 7248
2023
Q1 		$787K Buy
37,000
+600
+2% +$15K ﹤0.01% 7456
2022
Q4 		$1.08M Buy
+36,400
New +$977K ﹤0.01% 6025
2022
Q2 		– Sell
-11,400
Closed -$500K – 12878
2022
Q1 		$500K Sell
11,400
-1,200
-10% -$56K ﹤0.01% 8967
2021
Q4 		$767K Buy
12,600
+6,300
+100% +$348K ﹤0.01% 7996
2021
Q3 		$262K Buy
+6,300
New +$220K ﹤0.01% 10902

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group's BCYC Position: Q1 2026 in Review

Susquehanna International Group reduced its Bicycle Therapeutics (BCYC) stake by 65% in Q1 2026, selling an estimated $403K and leaving 37,888 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #11829.

Susquehanna International Group first reported a position in BCYC in Q3 2021 and has held it in 10 quarters since. The position peaked at $1.6M in Q2 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Susquehanna International Group held 37,888 shares of Bicycle Therapeutics worth $176K as of Q1 2026.
  • Susquehanna International Group sold 70,535 Bicycle Therapeutics shares in Q1 2026, an estimated $403K.
  • Bicycle Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11829 holding.
  • Susquehanna International Group first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 10 quarters since.
  • Susquehanna International Group's Bicycle Therapeutics position peaked at $1.6M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.